Abstract
Background and Aim: Non-invasive tests (NITs) are utilized as screening tools, prior to liver biopsy, for assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD). Data from Asian countries suggest that these tests have poor performance. We aimed to assess the performance of existing NITs to predict the presence of advanced fibrosis (AF) and identify an optimum combination of biomarker-based NIT and transient elastography (TE).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
